Anderon secures $1 billion quantum award

• Anderon, an IBM company, finalized a $1 billion CHIPS and Science Act award for quantum wafer manufacturing R&D.
• The company operates a 300-millimeter pure-play quantum wafer foundry in Albany, New York.
• IBM is providing an additional $1 billion investment to support the facility’s development.

Anderon, an IBM (NYSE:IBM) company, finalized a $1 billion CHIPS and Science Act award with the U.S. Department of Commerce to accelerate research and development for U.S.-based quantum wafer manufacturing.

The award supports Anderon’s 300-millimeter pure-play quantum wafer foundry in Albany, New York, which focuses on producing specialized wafers for superconducting quantum technologies.

Anderon said the facility is developing wafers for high-performance superconducting qubit arrays, quantum input/output signaling, and readout signal chain components, while IBM is providing an additional $1 billion investment.

Anderon has begun running its first quantum wafers through the Albany facility, which the company said demonstrates early production capability and the ability to move research technologies toward commercial manufacturing.

Anderon focuses on quantum semiconductor manufacturing and supports the development of specialized wafer technologies for quantum computing systems.

The company plans to expand its manufacturing capabilities to support additional quantum technology approaches beyond superconducting qubit-based systems.